Publicaciones en colaboración con investigadores/as de University of California, Irvine (22)

2024

  1. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  2. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation (Diabetologia, (2022), 65, 8, (1375-1389), 10.1007/s00125-022-05729-y)

    Diabetologia

  3. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

2023

  1. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis

    CMAJ. Canadian Medical Association Journal, Vol. 66, Núm. 3, pp. E310-E320

2022

  1. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389

2021

  1. Effects of fasting and feeding on transcriptional and posttranscriptional regulation of insulin‐degrading enzyme in mice

    Cells, Vol. 10, Núm. 9

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Modulation of insulin sensitivity by insulin-degrading enzyme

    Biomedicines, Vol. 9, Núm. 1, pp. 1-38

2020

  1. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

    Metabolism: Clinical and Experimental, Vol. 113

  2. The urgent need for integrated science to fight COVID-19 pandemic and beyond

    Journal of Translational Medicine, Vol. 18, Núm. 1

2019

  1. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity

    American journal of physiology. Endocrinology and metabolism, Vol. 317, Núm. 5, pp. E805-E819

  2. The underutilization of EUS-guided biliary drainage: Perception of endoscopists in the East and West

    Endoscopic Ultrasound, Vol. 8, Núm. 3, pp. 188-193

2018

  1. Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice

    Metabolism: Clinical and Experimental, Vol. 88, pp. 1-11

  2. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204

  3. Patient perception and preference of EUS-guided drainage over percutaneous drainage when endoscopic transpapillary biliary drainage fails: An international multicenter survey

    Endoscopic Ultrasound, Vol. 7, Núm. 1, pp. 48-55

2017

  1. Understanding and utilizing the biomolecule/nanosystems interface

    Nanotechnologies in Preventive and Regenerative Medicine: An Emerging Big Picture (Elsevier), pp. 207-297

2015

  1. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

    Nature Genetics, Vol. 47, Núm. 2, pp. 164-171

2014

  1. Interactions between herpesvirus entry mediator (TNFRSF14) and latency-associated transcript during herpes simplex virus 1 latency

    Journal of Virology, Vol. 88, Núm. 4, pp. 1961-1971

  2. Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain

    Pharmacological Research, Vol. 87, pp. 87-93

2013

  1. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    New England Journal of Medicine, Vol. 369, Núm. 26, pp. 2492-2503